Podcasts about Synthetic biology

De-extinction is no longer just science fiction. In this episode, we dive into the controversial concept of bringing back extinct species—specifically the dire wolf—using cutting-edge genetic engineering. Inspired by the headline-grabbing efforts to resurrect woolly mammoths, scientists are now exploring how DNA from ancient canids could be used to reintroduce this Ice Age predator into modern ecosystems. Genetic engineering plays a central role in this story. From piecing together fragmented DNA to editing modern genomes, researchers face significant scientific, ethical, and ecological hurdles. What would it mean to bring back a dire wolf? Would the creature truly be a dire wolf—or a hybrid imitation? We explore what's possible, what's fantasy, and what responsibilities come with resurrecting the past. Follow a career in conservation: https://www.conservation-careers.com/online-training/ Use the code SUFB to get 33% off courses and the careers program.   Do you want to join my Ocean Community? Sign Up for Updates on the process: www.speakupforblue.com/oceanapp   Sign up for our Newsletter: http://www.speakupforblue.com/newsletter   Facebook Group: https://bit.ly/3NmYvsI Connect with Speak Up For Blue: Website: https://bit.ly/3fOF3Wf Instagram: https://bit.ly/3rIaJSG TikTok: https://www.tiktok.com/@speakupforblue Twitter: https://bit.ly/3rHZxpc YouTube: www.speakupforblue.com/youtube  

Join us for an insightful conversation with Dr. Nadav Ahituv, a leader in human genetics and gene regulation at UCSF. He shares his personal journey from scoliosis patient to genetic researcher, exploring the mysteries of non-coding DNA, massively parallel reporter assays, and CRISPR-based therapeutic innovations.We dive into his lab's diverse projects, from decoding bat wing development and diet adaptation to tackling complex diseases like scoliosis and cancer through gene modulation. Learn how cloning is used alongside technologies like AI, genome-wide sequencing, and CRISPR to revolutionize our understanding of regulatory elements and shape the future of precision medicine.Plus, discover how a surprising approach—using modified fat cells—could be a game-changer in cancer therapy. This episode is a must-listen for anyone fascinated by the intersection of genetics, technology, and evolution. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Video - https://youtu.be/sDuA2q2JA5ASynthetic Biology blends engineering with biology to design new organisms or modify existing ones for tasks like producing biofuels, creating drought-resistant crops, or even cleaning up oil spills. It's a rapidly evolving field that holds the promise of transforming industries while raising important questions about ethics and safety—offering a glimpse into a future where tiny organisms might help solve some of humanity's biggest challenges.I used ChatGPT o1, VLC, ZOOM's Clips, ScreenPal, and Pictory.ai to put this information together.If you're interested in trying Pictory.ai please use the following link. https://pictory.ai?ref=t015o

AI isn't just growing—it's skyrocketing us into an unprecedented era of hyper-acceleration. Josh Kale joins us to explore how breakthroughs in intelligence, from protein sequencing and synthetic biology to autonomous transportation and energy abundance, are reshaping our world at dizzying speeds.  Prepare for a future that's closer than you think, where the cost of intelligence approaches zero and possibilities become boundless. ------

Greg Wu shares his transformative journey from high school in China to becoming an aspiring pioneer in synthetic biology. His story highlights critical educational opportunities at BioBuilder that shaped his passion for science and his future ambitions.• Greg's initial interest in natural sciences during high school • Discovering BioBuilder and its influence on his academic career • Experience in synthetic biology and engineering bacteria for unique projects • Transitioning to higher education in the US at Emory University • The value of interdisciplinary studies and collaborations with Georgia Tech • Future plans for a PhD in biomedical engineering and community engagement Learn more about BioBuilder's programs for students, educators, and industry professionals here

Professor Birger Lindberg Møller from Center for Synthetic Biology, Denmark, has always been impressed with the plant world and how plants can act as sun driven biochemical factories which can generate all the substances needed for growth and development of the plant. Plants can defend themselves with poison, they can signalise to each other and protect themselves against being eaten. Humans have domesticated plants for thousands of years. With genetic engineering plants can be developed to produce a large amount of different substances from medicine to food and they can protect themselves better against environmental changes and diseases. But the GMO approach has been controversial since the first GMO plants were launched in the 1990ies. Now Birger Lindberg Møller has another solution. Why not let the plants make their own natural mutations and select those which have the right genetic traits? It is possible to plant thousands of plants and select the very best with modern PCR screening. Photo credit: Jens Degett, © Science Stories ApS.

Recently, a group of world-leading scientists called for a halt on research to create ‘mirror life' microbes amid concerns that the synthetic organisms would present an ‘unprecedented risk' to life on Earth. Ian Sample tells Madeleine Finlay about why this work initially seemed exciting for scientists and what the risks of it continuing could be. And Kate Adamala, assistant professor of genetics, cell biology and development at the University of Minnesota, describes what made her change her mind about pursuing her own research on mirror cells. Help support our independent journalism at theguardian.com/sciencepod

Topics and terms such as biosafety, biosecurity, containment, and contamination are things most of us have heard of and think about at some level, but with the pace of molecular biology moving faster than ever, these are topics with implications that are reaching farther than ever. We're joined by Dr. Ryan Burnette and Dr. Lauren Richardson from Merrick and company for this episode, and they're ace communicators that help walk us through the expanding horizon and implications of these topics.This conversation starts on the basic topics, like what biocontainment is and what's needed for each of the four levels of biosafety labs, but it quickly moves beyond, shining a light on the security and containment needs for more than just the organisms. We hear about how the data and methods used to do modern molecular biology, as well as the data generated in the experiments, are equally precious and in need of protection and containment. With public health and safety on the line, and an acknowledgement that the pace of science moves faster than that of policy, we get into the idea of who really owns responsibility for protecting data. Your role might be more important than you know, so don't miss this conversation that will make you pause and think! Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Therapeutic antibodies are a vital weapon in combating diseases such as cancer, but developing these treatments through conventional methods is slow and unreliable. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Dr James Field, founder and CEO of LabGenius, a drug discovery company pioneering the discovery of next-generation therapeutic antibodies in order to solve this predicament. Dr Field speaks to how can industry cut through the hype that surrounds AI and optimally assess the technical underpinnings of an AI proposition in medicine. He describes how LabGenius overcomes the so-called “cognition barrier” by using mathematical models to understand how molecules will respond to disease, and then designs novel therapeutics with the right collection of properties. You can listen to episode 164a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, Amazon Music, Podbean, and pretty much wherever you get your other podcasts!

Video - https://youtu.be/R6mr_fZkxao Discover the fascinating world of synthetic biology, where science meets innovation to reshape our future. From groundbreaking gene-editing tools to sustainable bio-manufacturing, this revolutionary field promises personalized medicine, eco-friendly materials, and solutions to some of the planet's biggest challenges. Dive into a story of possibility and progress—where the building blocks of life are reimagined for a better tomorrow. I used DeepSeek, ChatGPT-4o, VLC, ScreenPal, and Pictory.ai to put this information together. If you're interested in trying Pictory.ai please use the following link. https://pictory.ai?ref=t015o

Imagine a future in which Band-Aids talk to your cells, pacemakers are powered by light and your gut microbiome gets a tune-up—all thanks to tiny bioelectric devices. Sounds like sci-fi, right? Think again. Prof. Bozhi Tian of the University of Chicago is on the frontier of bioelectronics, building living machines that can heal, enhance and maybe even transform what it means to be human. In this episode, he explains his research lab's work and explores the thrilling, strange and sometimes unsettling world in which biology meets technology.

In this episode of the Technology & Security podcast, host Dr. Miah Hammond-Errey is joined by Dr Thom Dixon, whose work explores biofutures and the bioeconomy. We explore what synthetic biology and bioinformation are and how much of an individual person's information signature is biological. We discuss how AI can learn from biomimicry and adaptive natural biological systems. We explore the future of surveillance plants and how sensing in the environment will operate and what it might mean for national and physical security as well as how a future consumer synthetic biology app will accelerate the fields growth and reach.The conversation covers Australian biodiversity and potential for functionally useful genetic traits to adapt to climate change as well as role of synthetic biology in climate adaptation and accounting, such as carbon cycling and increasing carbon uptake. This episode includes a quick look at some security threats, including the pervasiveness of DNA data collection (and inability to protect DNA instances), role of AI in mediating information and its potential in influence and interference campaigns. Finally, we discuss the need for policy makers to better understand biology. As we see an increase in cyber-physical (and environmental) systems, policy makers need to improve their understanding of biology and how it interacts with technology.  Thom Dixon completed his PhD at Macquarie University. It explores the development of and use of bioinformation and synthetic biology can impact international relations. He was the Vice President for the Australian Institute of International Affairs NSW. He is a member of the ARC Centre for Excellence for Synthetic Biology and the manager, national security and defence for Macquarie University. Resources mentioned in the recording: + Model's of Life: https://defencescienceinstitute.com/funding-opportunity/darpa-biological-technologies-hr001124s0034/+ The Substack: https://biofuturesinstantiated.substack.com/ This podcast was recorded on the lands of the Gadigal people, and we pay our respects to their Elders past, present and emerging. We acknowledge their continuing connection to land, sea and community, and extend that respect to all Aboriginal and Torres Strait Islander people. Music by Dr Paul Mac and production by Elliott Brennan. 

In this engaging conversation on the Crazy Wisdom podcast, Stewart Alsop talks with neurologist Brian Ahuja about his work in intraoperative neurophysiological monitoring, the intricate science of brainwave patterns, and the philosophical implications of advancing technology. From the practical applications of neuromonitoring in surgery to broader topics like transhumanism, informed consent, and the integration of technology in medicine, the discussion offers a thoughtful exploration of the intersections between science, ethics, and human progress. Brian shares his views on AI, the medical field's challenges, and the trade-offs inherent in technological advancement. To follow Brian's insights and updates, you can find him on Twitter at @BrianAhuja.Check out this GPT we trained on the conversation!Timestamps00:00 Introduction to the Crazy Wisdom Podcast00:21 Understanding Intraoperative Neurophysiological Monitoring00:59 Exploring Brainwaves: Alpha, Beta, Theta, and Gamma03:25 The Impact of Alcohol and Benzodiazepines on Sleep07:17 The Evolution of Remote Neurophysiological Monitoring09:19 Transhumanism and the Future of Human-Machine Integration16:34 Informed Consent in Medical Procedures18:46 The Intersection of Technology and Medicine24:37 Remote Medical Oversight25:59 Real-Time Monitoring Challenges28:00 The Business of Medicine29:41 Medical Legal Concerns32:10 Alternative Medical Practices36:22 Philosophy of Mind and AI43:47 Advancements in Medical Technology48:55 Conclusion and Contact InformationKey InsightsIntraoperative Neurological Monitoring: Brian Ahuja introduced the specialized field of intraoperative neurophysiological monitoring, which uses techniques like EEG and EMG to protect patients during surgeries by continuously tracking brain and nerve activity. This proactive measure reduces the risk of severe complications like paralysis, showcasing the critical intersection of technology and patient safety.Brainwave Categories and Their Significance: The conversation provided an overview of brainwave patterns—alpha, beta, theta, delta, and gamma—and their connections to various mental and physical states. For instance, alpha waves correspond to conscious relaxation, while theta waves are linked to deeper relaxation or meditative states. These insights help demystify the complex language of neurophysiology.Transhumanism and the Cyborg Argument: Ahuja argued that humans are already "cyborgs" in a functional sense, given our reliance on smartphones as extensions of our minds. This segued into a discussion about the philosophical and practical implications of transhumanism, such as brain-computer interfaces like Neuralink and their potential to reshape human capabilities and interactions.Challenges of Medical Technology Integration: The hype surrounding medical technology advancements, particularly AI and machine learning, was critically examined. Ahuja highlighted concerns over inflated claims, such as AI outperforming human doctors, and stressed the need for grounded, evidence-based integration of these tools into healthcare.Philosophy of Mind and Consciousness: A recurring theme was the nature of consciousness and its central role in both neurology and AI research. The unresolved "hard problem of consciousness" raises ethical and philosophical questions about the implications of mimicking or enhancing human cognition through technology.Trade-offs in Technological Progress: Ahuja emphasized that no technological advancement is without trade-offs. While tools like CRISPR and mRNA therapies hold transformative potential, they come with risks like unintended consequences, such as horizontal gene transfer, and the ethical dilemmas of their application.Human Element in Medicine: The conversation underscored the importance of human connection in medical practice, particularly in neurology, where patients often face chronic and emotionally taxing conditions. Ahuja's reflections on the pitfalls of bureaucracy, private equity in healthcare, and the overemphasis on defensive medicine highlighted the critical need to prioritize patient-centered care in an increasingly technological and administrative landscape.

Part 2 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI. Rafael, a biomedical research veteran, combines academic excellence with industry innovation. A Dartmouth graduate with a Yale doctorate, he conducted postdoctoral research at Lawrence Berkeley National Laboratory, where he co-invented the j5 DNA assembly tool. As co-founder of the Alliance for AI in Healthcare, he advocates for responsible AI integration in medicine, drawing from his extensive background in evolution, immunology, bioengineering, and genetics.

Part 4 of 4: My guest today is Cyriac Roeding, founder, investor, and CEO of Earli, a company on a mission to transform cancer into a manageable condition. Using innovative gene therapy approaches, Earli's technology forces cancer cells to produce a synthetic, non-human biomarker—overcoming the limitations of relying on naturally occurring biomarkers that cancer may or may not provide.

Listen Ad Free https://www.solgoodmedia.com - Listen to hundreds of audiobooks, thousands of short stories, and ambient sounds all ad free!

In this episode of The Big Experiment, we are live, recording from the Synthetic Biology UK 2024 conference hosted by the Biochemical Society, at Hinxton Hall near Cambridge, home of the famous Genome Campus.Synthetic biology is the practice of manipulating biology to achieve outcomes that don't occur naturally or in some cases are not naturally possible. Common examples include producing new proteins for therapeutic use, but there are many other applications of lab-derived augmentation of living things.These include making meat without killing animals, altering plant photosynthesis to improve crop production, using bacteria to clean up contaminated soils, making new vaccines and antibiotics before we need them, and many more.See here for the Biochemical Society's useful resource page on this subject, which has lots of articles and info: Synthetic Biology.There were too many fantastic applications to cover in one show, but I hope this episode gives you an idea of the potential. I take my roving microphone on a tour of the event, talking to researchers showcasing their work. We hear about a wide range of studies including creating affordable CRISPR diagnostics, engineering synthetic microbial communities for enhanced bio-production, and much more.This episode showcases the future of synthetic biology and some of the great advances we can expect. In some cases, as you'll hear, I hope we don't ever need to use them.It also highlights some amazingly talented young scientists at the coalface of scientific discovery. The professors of tomorrow.“It's amazing we can do things in the lab that evolution hasn't thought of.” – MarkYou'll hear about:01:10 - What is synthetic biology?04:06 - Therapeutics from engineering biology: how and why 08:11 - Ana Pascual Cambridge Uni - CRISPR diagnostics for all?12:36 - Casey Chen UCL - Making new microbial communities15:58 - Mark's poster tour interlude19:48 - Gabrielle Admans Cambridge Uni - Predicting vaccines before pandemics22:08 - Giuliano Bonfa, Italian Inst Tech - T-rEx fights solid tumours?25:42 - Max Armitage Nottingham Uni - Finding new antibioticsConnect with the Biochemical Society:Website - https://www.biochemistry.org/X - https://x.com/BiochemSocConnect with me:LinkedIn: https://www.linkedin.com/in/markdavison100/ If you need any lab equipment:Grant Instruments: https://www.grantinstruments.com/ Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/ 

"Unlocking the Mysteries of Mind and Matter: Professor Michael Levin's Quantum Insights on The Dov Baron Show" . Introduction: In this episode of "The Dov Baron Show," we're once again stepping into a riveting exploration of the boundaries where science meets consciousness. Join us as Professor Michael Levin, a distinguished figure at the forefront of developmental biophysics and synthetic biology, unveils groundbreaking research that could revolutionize our understanding of life itself. . We'll pull back the curtain on regenerative medicine and examine the synthetic biology of novel life forms. Professor Levin's work at Tufts University and Harvard's Weiss Institute challenges our conventional views on biology and technology. . Prepare to expand your perception of reality in this mind-bending journey into quantum effects. Join us on "The Dov Baron Show" as we unravel these profound insights with Professor Michael Levin, challenging what we know about life, intelligence, and the very fabric of reality. . Key Learnings: The Essence of Curiosity: Understand why curiosity is not just beneficial but essential in today's complex world, helping us navigate immense social and scientific challenges.   Science vs. Dogma: Explore the tension between established scientific paradigies and the openness required for innovative breakthroughs. . The Inertia of Ideas: Learn about the systemic inertia that often prevents new scientific ideas from being accepted and how it compares to religious dogmatism. . Redefining Intelligence: Discover a broader, more inclusive definition of intelligence that goes beyond human capacities and encompasses a wide range of life forms. . Problem Solving Across Species: Examine how different organisms and systems solve problems and adapt to their environments, redefining our concepts of intelligence. . The Role of Autonomy in Intelligence: Delve into how autonomy and problem-solving capabilities contribute to our understanding of intelligence across various domains. . Scientific Methodology in Questioning Beliefs: Learn the importance of establishing clear criteria for changing one's scientific or personal viewpoints, promoting a more dynamic and flexible approach to knowledge. . Dov Baron's brand new course has just been released on coursifyx.com/belonging ------------- Titled: "CREATING A CULTURE OF BELONGING." The course is divided into eight sections, each of which will guide you through exactly how to create a culture of belonging. . Because: CREATING A CULTURE OF BELONGING MAXIMIZES PERSONAL AND CORPORATE SUCCESS. Get Ready to strap on the tanks and Dive Deep into, What it Takes to Create a Culture of Belonging in your organization! Curious to know more? coursifyx.com/belonging .  "Those Who Control Meaning for The Tribe, Also Control The Movement of That Tribe" #leadership #leadershipdevelopment #emotionsourcecode #neuroscience #emotional #meaning #emotional #logic #culture #curiosity #humanbehavior

Jeffrey Ladish is the director of Palisades research, and AI safety organization based in the San Francisco Bay. Our previous conversations about the dangers of AI left us insufficiently concerned. Ladish takes up the mantle of trying to convince us that there's something worth worrying about by detailing the various projects and experiments that Palisades has been undertaking with the goal of demonstrating that AI agents let loose on the world are capable of wreaking far more havoc than we expect. We leave the conversation more wary of the machines than ever - less because we think hyper-intelligent machines are just around the corner, and more because Ladish paints a visceral picture of the cage we're building ourself into. PATREON: get episodes early + join our weekly Patron Chat https://bit.ly/3lcAasB MERCH: Rock some DemystifySci gear : https://demystifysci.myspreadshop.com/ AMAZON: Do your shopping through this link: https://amzn.to/3YyoT98 (00:00) Go! (00:07:36) Risks from Nuclear Wars and Emerging Technologies (00:15:01) Experiments with AI Agents (00:25:11) Enhanced AI as Tools vs. Intelligent Agents (00:34:39) AI Learning Through Games (00:44:04) AI Goal Accomplishment (00:55:01) Intelligence and Reasoning (01:07:11) Technological Arms Race and AI (01:17:16) The Rise of AI in Corporate Roles (01:25:20) Inception and Incentivization Issues in AI (01:35:12) AI Threats and Comparisons to Bioterrorism (01:45:13) Constitutional Analogies and Regulatory Challenges (01:55:11) AI as a Threat to Human Control (02:07:02) Challenges in Managing Technological Advancements (02:16:49) Advancements and Risks in AI Development (02:25:01) Current AI Research and Public Awareness #FutureOfAI, #AlgorithmicControl, #Cybersecurity, #AI, #AISafety, #ArtificialIntelligence, #TechnologyEthics, #FutureTech, #AIRegulation, #AIThreats, #Innovation, #TechRisks, #Cybersecurity, #SyntheticBiology, #TechGovernance, #HumanControl, #AIAlignment, #AIAdvancement, #TechTalk, #Podcast, #TechEthics, #sciencepodcast, #longformpodcast Check our short-films channel, @DemystifySci: https://www.youtube.com/c/DemystifyingScience AND our material science investigations of atomics, @MaterialAtomics https://www.youtube.com/@MaterialAtomics Join our mailing list https://bit.ly/3v3kz2S PODCAST INFO: Anastasia completed her PhD studying bioelectricity at Columbia University. When not talking to brilliant people or making movies, she spends her time painting, reading, and guiding backcountry excursions. Shilo also did his PhD at Columbia studying the elastic properties of molecular water. When he's not in the film studio, he's exploring sound in music. They are both freelance professors at various universities. - Blog: http://DemystifySci.com/blog - RSS: https://anchor.fm/s/2be66934/podcast/rss - Donate: https://bit.ly/3wkPqaD - Swag: https://bit.ly/2PXdC2y SOCIAL: - Discord: https://discord.gg/MJzKT8CQub - Facebook: https://www.facebook.com/groups/DemystifySci - Instagram: https://www.instagram.com/DemystifySci/ - Twitter: https://twitter.com/DemystifySci MUSIC: -Shilo Delay: https://g.co/kgs/oty671

In this episode of Life-Changing Science, we sit down with Nicolas Rojas Taborda​, a senior at Revere High School. Nico's interests shifted dramatically thanks to his involvement in the BioBuilder Apprenticeship Challenge. Nico describes his discovery of synthetic biology and his team's project idea, the K Detective, an innovative at-home kit for cavity detection. This project not only sharpened his technical prowess with tools like PCR and gel electrophoresis but also positioned him to succeed in his Boston University STEM pathway internship building logic gates for CAR-T cells, and as a leader of his high school's iGEM team. Nico shares his future aspirations in the realm of synthetic biology and education. Considering roles as a mentor or teacher with BioBuilder, he reflects on the fulfilling nature of educational roles. Moreover, he describes the Christian A. Herter Memorial Scholarship application process, sharing tips on requesting a standout letter of recommendation and defining a clear career vision. This episode wraps up with his process investigating potential college majors and his dreams to someday launch a biotech company.  Nico emphasizes the foundational impact BioBuilder has had on his journey. This episode is not just an exploration of one student's evolution but a testament to the life-changing possibilities of early scientific engagement.Learn more about BioBuilder's programs for students, educators, and industry professionals here

Total Runtime: 2:33.25 @ www.sheepfarm.co.uk Elana Freeland is a writer, ghost-writer, teacher and lecturer who researches and writes on Deep State issues like geoengineering, MK-ULTRA, ritual abuse, targeting and invasive electromagnetic weapons.She is best known for her geoengineering trilogy Chemtrails, HAARP, and the Full Spectrum Dominance of Planet Earth (Feral House, June 2014; also in Serbian), Under An Ionized Sky: From Chemtrails to Space Fence Lockdown ​(Feral House, February 2018; also in Dutch), and Geoengineered Transhumanism: How the Environment Has Been Weaponized by Chemicals, Electromagnetism, & Nanotechnology for Synthetic Biology.Now, she posts news and commentary at https://www.patreon.com/ElanaFreelandand her one Facebook site left at EMF Planetary Engineering.See her also at Twitter, Odysee, Bitchute, and YouTube. HElana's historical website designed by Frankie Styles is at https://www.elanafreeland.com. Richard D. Hall - Legal Fund (richplanet.net) https://www.richplanet.net/donatelegal.phpSheep Farm www.sheepfarm.co.uk https://www.youtube.com/@sheepfarmstudios2921/videoshttps://www.podomatic.com/podcasts/sheepfarmstudioshttps://rumble.com/user/SheepFarmStudiohttps://odysee.com/@sheepfarmstudios:fDom's Health Bunker Supplements www.shop.healthbunker.co.ukUse discount Codes HB-SF10OFF for NEW Liposomal Vitamin C & HB-SF25OFF for all HB other Products. But discount codes can be used at checkout.*Discount Codes only available on Health Bunker Products*Health Bunker Clinic www.healthbunker.co.ukChris's Gaping Gobs - Etsy UK

It's always interesting to think about how many technologies that we take for granted today, such as genome sequencing and bioengineering, were completely unheard of just a few decades ago. This episode, we're going back to the roots of these applications with Dr. James Collins, who is widely regarded as one of the founders of the field of synthetic biology. Tune in to hear his thoughts on the importance of leveraging the tools we have today for pandemic prevention and readiness, how to reframe thinking around biosecurity when it comes to applications of these technologies, and how AI can help us outrun antibiotic resistance with rapid drug discovery.Dr. James Collins is a professor of medical engineering and science at MIT, a core faculty member at the Wyss Institute of Harvard University, and a member of the Broad Institute of MIT and Harvard. He is a member of the National Academies of Engineering, Science, and Medicine, and his technologies have been licensed by over 25 biotech and medical device companies.

In this episode, we welcome Shalini Yadav, a 2024 Executive MBA graduate and visionary leader in the field of synthetic biology. With over 22 years of research experience, including a decade in leadership, Shalini has a deep expertise in synthetic biology, immuno-oncology, and therapeutics. She now serves as the Executive Director of Rice's Synthetic Biology Institute, where she spearheads cutting-edge research, fosters interdisciplinary collaboration, and drives the institute's mission to unlock synthetic biology's transformative potential.Host Maya Pomroy '22 speaks with Shalini about her inspiring journey from growing up in Allahabad, India, to leading translational cancer research at MD Anderson Cancer Center in Houston. Shalini reflects on how her early experiences with infectious diseases and her education, from New Delhi to Stony Brook University, shaped her passion for synthetic biology. She also shares her thoughts on the field's potential to revolutionize science and the critical role of integrating business strategy into scientific innovation.Episode Guide:02:39 Early Life and Education04:13 Challenges and Adventures in the US07:08 Groundbreaking Research and Discoveries10:00 Transition to Translational Research14:23 Journey to MD Anderson and Houston17:17 Why Pursue an MBA Now?27:16 Synthetic Biology: The Next Scientific Revolution37:48 Future Aspirations and ConclusionOwl Have You Know is a production of Rice Business and is produced by University FM.Episode Quotes:How a serendipitous opportunity brought Shalini to Houston14:09: [Maya Pomroy] So what brought you to Houston? Was it MD Anderson that brought you to Houston?14:35: [Shalini Yadav] When I got an opportunity, again grateful to the PCF Young Investigator Award that I got, this network of people that I met, and through that, I was able to connect with Dr. Allison, and it, again, serendipitously, happened that he, looking at my expertise and things that I had done, said, “Would you like to do this work, which is a lot of scientific management and administrative?” [15:06] I thought, okay, as long as I found it interesting and exciting, because, again, I was handling multiple stakeholders and trying to work with multiple pharmaceutical companies, different departments, different kinds of experts, working together with all of them to handle a scientific problem, which will actually help to learn something new. So that was very satisfying to do that.How an MBA gave Shalini a new perspective on impact32:42: I would like to say that scientists in general are passionate about what they do. It's the leap that you have to take that overcome, and your perspective changes after MBA. I never had this perspective. The way I understand things now are completely different than I would have done two years back. 33:18: So if community matters to you and if you're bothered by things around you, which you want to change and you think with this you cannot. I think taking that leap where you will learn things, which I think basically as a scientist, our training as graduate students, or even medical studies, we are taught to be very focused. So having to come out of that shell and embrace this bigger picture and having the strength to think about what impact I can have because if you understand both sides of it, what you can think of achieving, you won't get it if you are just on one side of things. The effect of bridging the gap between clinical and translational research and basic research11:35: When you bring diverse expertise together, the solutions that come out have way more value and are more impactful than what you can achieve alone. So bridging this gap was not something that I was looking for, but I serendipitously got into a position where I just did what was needed, which gave me a very different perspective of what scientific research can achieve in terms of, if you understand the problems which people are actually facing, then your solutions can be tailored, or you can design proposals to address those problems.Show Links: TranscriptGuest Profiles:Shalini Yadav | LinkedInRice Synthetic Biology Institute MD Anderson Cancer CenterYoung Investigator Awards | Prostate Cancer FoundationWorld Health Organization Catch our previous episode with Jillian Lebovitz Fink: "A Former Fourth-Grade Teacher Is Working to Ease Your Migraines." Listen now: https://business.rice.edu/owlhaveyouknow/season-3-episode-16

What is life? Neil deGrasse Tyson and co-host Chuck Nice tackle assembly theory, artificial life, and the origin of lifeforms in the universe as we revise the definition of life with astrobiologist and theoretical physicist Sara Imari Walker.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/the-origins-of-life-with-sara-imari-walker/Thanks to our Patrons Bill Williamson, Amanda, Charles Waggoner, Jason Wiatr, Don Lane, Biren Amin, Jean C Roy, david accetta, STAHLGEIST, joshua george, Danny, daniel oliveira, Matthew Szwajda, Gabe Magallanes, Mike Jespersen, Elias, and Jon O for supporting us this week. Subscribe to SiriusXM Podcasts+ on Apple Podcasts to listen to new episodes ad-free and a whole week early.

This week, we're diving deep into some really clever and cutting-edge tech for Martian habitats... made from fungus! Dr. Lynn Rothschild of the NASA Ames Research Center has been working for years on how mushroom mycelia might be utilized as a habitat-building resource. It's quite fascinating--the organic material can be used to make bricks, to create shaped structures, and even to create an "astropharmacy" to supply certain compounds needed by the crew of a Mars excursion! And it is sufficiently enticing that NASA's NIAC innovation program has given her no less than five grants (which are not easy to get!) to study the possibilities. Join us for this really engaging and blue-sky conversation! Headlines: • ISS has been experiencing a slow air leak, increasing from 0.2 pounds per day to 3.7 pounds per day, causing concern for NASA's Office of the Inspector General • Jupiter's Great Red Spot has been shrinking and "pulsing" over time, as observed by the Hubble Space Telescope, with scientists predicting it will eventually stabilize as a smaller, circular storm • A rare G4-class solar storm triggered widespread auroras visible at much lower latitudes than usual, with NOAA issuing warnings to protect power grids and communication systems Main Topic - Living in Martian Mushrooms: • Dr. Rothschild explains synthetic biology as creating something new with biology, either by altering existing organisms or creating new ones from scratch • The concept of using fungal mycelium for off-world habitats originated from a student project to create a biodegradable drone body • Mycotecture involves growing habitats and structures using mycelium, which can bind various materials like sand, regolith simulant, and wood chips • The properties of mycelium-based materials can be tuned by adjusting the substrate and post-processing, ranging from styrofoam-like to hardwood-like consistencies • Dr. Rothschild's vision for a stable off-world habitat includes using cyanobacteria to process atmospheric gases and minerals, which would then feed the fungi used in construction • Cross-contamination concerns on Mars are addressed, with the lack of liquid water on the surface making it unlikely for introduced organisms to thrive • Additional applications of mycelium-based technology include biomining, water filtration, and even food production • Dr. Rothschild also discusses the Astro Pharmacy project, which aims to develop an on-demand drug production system for astronauts • While these technologies have significant potential for Earth-based applications, developing them for space allows for more freedom to explore revolutionary ideas without existing infrastructure constraints Hosts: Rod Pyle and Tariq Malik Guest: Dr. Lynn Rothschild Download or subscribe to this show at https://twit.tv/shows/this-week-in-space. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit Sponsors: uscloud.com veeam.com

What role does creativity play in navigating an unpredictable world?On this episode, I sit down with Carissa Carter and Scott Doorley, both professors at the Stanford d.school. Together, they've co-authored Assembling Tomorrow, a fascinating exploration of how design influences the future, especially amidst the rapid rise of emerging technologies like AI and synthetic biology. We discuss how design shapes the environments we live and work in and why getting it right can help people make better, safer, and more ethical choices.Our conversation dives into some intriguing concepts like “mischievous materials” and the role that design fiction plays in imagining the future. Carissa and Scott share their insights into the power of speculative fiction, demonstrating how it can help us predict and adapt to the future consequences of today's decisions. We also discuss how design often starts as fiction and evolves into real-world innovations and how emotions and make-believe play crucial roles in the creative process. Lastly, we discuss the ethical implications of design and the importance of considering all possible outcomes—positive and negative—when creating new tools or systems. The discussion is both a hopeful and realistic look at how designers, and indeed all of us, can better navigate an increasingly unpredictable world. Biography of the Guests: Carissa Carter is a designer, geoscientist, and the academic director at the Stanford d.school. She teaches design courses focused on emerging technologies, climate change, and data visualization, helping students apply design thinking to complex, real-world challenges. Carissa is passionate about exploring how design can foster creativity, ethical decision-making, and positive societal impact. Scott Doorley is the creative director at the Stanford d.school, where he oversees a wide array of projects, including books, workspaces, digital products, and initiatives aimed at shaping the future of learning and design. A designer and writer, Scott has a deep interest in how design can be used as a tool for understanding and influencing human behaviour, particularly in times of rapid technological and societal change.Together, Carissa and Scott have co-authored Assembling Tomorrow, a book that delves into how emerging technologies influence human behaviour, decision-making, and ethics. They use the power of storytelling and speculative fiction to imagine future scenarios and provoke thought on how design can guide us through an increasingly complex world.LinksCarissa's profile - https://dschool.stanford.edu/team-directory/carissa-l-carterScott's profile - https://dschool.stanford.edu/team-directory/scott-doorleyThe Stanford d School - https://dschool.stanford.edu/Assembling Tomorrow and other d School books - https://dschool.stanford.edu/booksAI-Generated Timestamp Summary[00:00:00] Introduction and welcome [00:00:33] How design shapes our environments and influences decision-making[00:01:00] Introduction to Stanford d.school and the work of Carissa and Scott [00:01:41] Overview of Assembling Tomorrow and its exploration of emerging tech[00:02:20] Ethical implications of design and the influence of emerging technologies [00:03:16] Carissa and Scott introduce themselves and their work[00:04:36] The role of ambiguity in design and navigating uncertainty[00:06:24] Emotions and make-believe in the design process [00:08:19] Importance of seeing the full impact of design decisions[00:10:07] The dynamic of young versus experienced creators in technology[00:15:35] Speculative fiction as a tool for imagining future design consequences [00:17:23] The process behind creating Assembling Tomorrow[00:22:04] Strategies for solving complex problems in an unpredictable world[00:23:14] Embracing awkwardness and aiming for imperfection in design [00:26:35] Need to adapt to more organic, unpredictable processes in design [00:33:04] Developing an ethical mindset within design education[00:36:00] Generational shift in attitudes towards ethical design[00:45:11] Visuals and illustrations as tools for engaging readers in design concepts

This week, we're diving deep into some really clever and cutting-edge tech for Martian habitats... made from fungus! Dr. Lynn Rothschild of the NASA Ames Research Center has been working for years on how mushroom mycelia might be utilized as a habitat-building resource. It's quite fascinating--the organic material can be used to make bricks, to create shaped structures, and even to create an "astropharmacy" to supply certain compounds needed by the crew of a Mars excursion! And it is sufficiently enticing that NASA's NIAC innovation program has given her no less than five grants (which are not easy to get!) to study the possibilities. Join us for this really engaging and blue-sky conversation! Headlines: • ISS has been experiencing a slow air leak, increasing from 0.2 pounds per day to 3.7 pounds per day, causing concern for NASA's Office of the Inspector General • Jupiter's Great Red Spot has been shrinking and "pulsing" over time, as observed by the Hubble Space Telescope, with scientists predicting it will eventually stabilize as a smaller, circular storm • A rare G4-class solar storm triggered widespread auroras visible at much lower latitudes than usual, with NOAA issuing warnings to protect power grids and communication systems Main Topic - Living in Martian Mushrooms: • Dr. Rothschild explains synthetic biology as creating something new with biology, either by altering existing organisms or creating new ones from scratch • The concept of using fungal mycelium for off-world habitats originated from a student project to create a biodegradable drone body • Mycotecture involves growing habitats and structures using mycelium, which can bind various materials like sand, regolith simulant, and wood chips • The properties of mycelium-based materials can be tuned by adjusting the substrate and post-processing, ranging from styrofoam-like to hardwood-like consistencies • Dr. Rothschild's vision for a stable off-world habitat includes using cyanobacteria to process atmospheric gases and minerals, which would then feed the fungi used in construction • Cross-contamination concerns on Mars are addressed, with the lack of liquid water on the surface making it unlikely for introduced organisms to thrive • Additional applications of mycelium-based technology include biomining, water filtration, and even food production • Dr. Rothschild also discusses the Astro Pharmacy project, which aims to develop an on-demand drug production system for astronauts • While these technologies have significant potential for Earth-based applications, developing them for space allows for more freedom to explore revolutionary ideas without existing infrastructure constraints Hosts: Rod Pyle and Tariq Malik Guest: Dr. Lynn Rothschild Download or subscribe to this show at https://twit.tv/shows/this-week-in-space. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit Sponsors: uscloud.com veeam.com

This week, we're diving deep into some really clever and cutting-edge tech for Martian habitats... made from fungus! Dr. Lynn Rothschild of the NASA Ames Research Center has been working for years on how mushroom mycelia might be utilized as a habitat-building resource. It's quite fascinating--the organic material can be used to make bricks, to create shaped structures, and even to create an "astropharmacy" to supply certain compounds needed by the crew of a Mars excursion! And it is sufficiently enticing that NASA's NIAC innovation program has given her no less than five grants (which are not easy to get!) to study the possibilities. Join us for this really engaging and blue-sky conversation! Hosts: Rod Pyle and Tariq Malik Guest: Dr. Lynn Rothschild Download or subscribe to this show at https://twit.tv/shows/this-week-in-space. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit Sponsors: uscloud.com veeam.com

This week, we're diving deep into some really clever and cutting-edge tech for Martian habitats... made from fungus! Dr. Lynn Rothschild of the NASA Ames Research Center has been working for years on how mushroom mycelia might be utilized as a habitat-building resource. It's quite fascinating--the organic material can be used to make bricks, to create shaped structures, and even to create an "astropharmacy" to supply certain compounds needed by the crew of a Mars excursion! And it is sufficiently enticing that NASA's NIAC innovation program has given her no less than five grants (which are not easy to get!) to study the possibilities. Join us for this really engaging and blue-sky conversation! Headlines: • ISS has been experiencing a slow air leak, increasing from 0.2 pounds per day to 3.7 pounds per day, causing concern for NASA's Office of the Inspector General • Jupiter's Great Red Spot has been shrinking and "pulsing" over time, as observed by the Hubble Space Telescope, with scientists predicting it will eventually stabilize as a smaller, circular storm • A rare G4-class solar storm triggered widespread auroras visible at much lower latitudes than usual, with NOAA issuing warnings to protect power grids and communication systems Main Topic - Living in Martian Mushrooms: • Dr. Rothschild explains synthetic biology as creating something new with biology, either by altering existing organisms or creating new ones from scratch • The concept of using fungal mycelium for off-world habitats originated from a student project to create a biodegradable drone body • Mycotecture involves growing habitats and structures using mycelium, which can bind various materials like sand, regolith simulant, and wood chips • The properties of mycelium-based materials can be tuned by adjusting the substrate and post-processing, ranging from styrofoam-like to hardwood-like consistencies • Dr. Rothschild's vision for a stable off-world habitat includes using cyanobacteria to process atmospheric gases and minerals, which would then feed the fungi used in construction • Cross-contamination concerns on Mars are addressed, with the lack of liquid water on the surface making it unlikely for introduced organisms to thrive • Additional applications of mycelium-based technology include biomining, water filtration, and even food production • Dr. Rothschild also discusses the Astro Pharmacy project, which aims to develop an on-demand drug production system for astronauts • While these technologies have significant potential for Earth-based applications, developing them for space allows for more freedom to explore revolutionary ideas without existing infrastructure constraints Hosts: Rod Pyle and Tariq Malik Guest: Dr. Lynn Rothschild Download or subscribe to this show at https://twit.tv/shows/this-week-in-space. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit Sponsors: uscloud.com veeam.com

Jim Thomas says profit driven generative biology, Big Tech integration of artificial intelligence with synthetic biology, raises serious challenges for global oversight of biotechnology and governments need to separate hype from reality at the upcoming 2024 UN Biodiversity Conference (CBD COP16). Produced by GPEnewsdocs.

In this episode, Aditya and Shambhavi discuss the new developments in biotechnology can can help create bioweapons and the likelihood of their use. All Things Policy is a daily podcast on public policy brought to you by the Takshashila Institution, Bengaluru. Find out more on our research and other work here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://takshashila.org.in/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Check out our public policy courses here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://school.takshashila.org.in⁠

Karl and Erum welcome Christina Smolke, CEO of Antheia and Professor at Stanford University, to discuss the rapid changes happening in biotech, particularly focusing on the biohacking community and decentralized science (DCI). Christina is developing revolutionary ways to manufacture critical pharmaceuticals using biotechnology. They explore the intersection of biohacking, pharmaceuticals, and emerging technologies. A key theme is the potential of biological processes to transform traditional methods, such as growing plants for medicine, into faster, scalable alternatives. Karl, Erum, and Christina talk about cutting-edge topics like longevity, decentralized research, and biotech's growing role in addressing global challenges such as drug shortages and sustainability. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 – Biotech Beginnings: Kicking off with the latest innovations in biotech. 00:00:16 – Event Recap Madness: A whirlwind of the hottest biotech events. 00:00:49 – Sci-Fi or Science?: Diving into decentralized science's wild future. 00:02:45 – The Vital Shift: Key moments from the cutting-edge biohacking event. 00:07:21 – DARPA's Big Moves: How AI and biotech are shaping the future of defense. 00:09:21 – A Conversation with Christina Smolke: Enter the world of biotech innovation with Antheia's visionary. 00:17:21 – The Manufacturing Dilemma: Tackling the challenges in pharmaceutical production. 00:28:14 – Antheia's Game-Changing Role: Transforming the pharmaceutical landscape. 00:29:22 – Supply Chain Solutions: Ensuring surety of supply for critical drugs. 00:30:22 – Biotech Scaling Mastery: How Antheia is leading synthetic biology to new heights. 00:35:23 – Government Backing Biotech: Why the U.S. is investing in synthetic biology. 00:39:10 – The Future of Pharma Manufacturing: Leapfrogging into more sustainable, faster production methods. 00:47:39 – Wisdom for Biotech Founders: Christina's must-hear advice for new leaders. 00:49:44 – Key Takeaways: Recapping the interview with reflections and insights. 00:53:02 – Tackling Drug Shortages: Addressing the global crisis with biotech innovation. 00:54:29 – Closing Connections: Final thoughts and how you can join the conversation. Topics Covered: biotech, bioengineering, precision fermentation, epigenetics, optogenetics, light, biosolutions, cellular control, photomolecular biology Episode Links: Antheia  DARPA Biological Technologies Office  JP Morgan Healthcare Conference DeSciNYC Compound VC Union Square Ventures Unnatural Selection on Netflix Josie Zayner David Cronenberg  Scavengers Reign animated series⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ /⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

You've heard of fruit leather, but what about making leather from fruit? Or more precisely, feeding fruit waste like mango pulp to bacteria which then convert those sugars into a leather-like material that can be useful for all types of purposes? That's exactly what Polybion, a startup in Central Mexico, is doing. Co-founded in 2015 by two brothers with a passion for using biology to save humanity from ourselves—as CEO Axel Gómez-Ortigoza puts it—Polybion has pioneered methods of turning the fruit industry's trash into what they hope will be their treasure. As you'll hear in this episode, Polybion has methods for treating fruit waste to make it economic as a feedstock in their fermentation system to grow cellulose into a leather-like material they call Celium. Already the company is partnered with fashion companies eager to put Celium into their menu of offerings. To sustainably feed and clothe ourselves into the future, it's imperative that we no longer go big with animal agriculture, but instead go small with microbial agriculture. Will Polybion's cellulose leather be a part of the solution? Time will tell. But for now, enjoy hearing the wild ride this company's been on from conception to pivoting technologies to getting a product out onto the market. Discussed in this episode You can see photos of Celium here. CNN on the partnership between Danish fashion brand Ganni and Polybion. Suzanne Lee was an inspiration for Polybion's founders. Ecovative also inspired them, and we did an episode with them too! Plastic-eating fungi offer hope Axel recommends reading Microcosmos and My Inventions. He also recommends watching the original Carl Sagan Cosmos TV series from the 1980s. (The 2014 remake with Neil deGrasse Tyson is also great.) Guillermo González Camarena was an engineer who served as an inspiration to Axel.  More about Axel Gómez-Ortigoza Axel Gómez-Ortigoza was born with an innate fascination for the mysteries of life, the natural world, and the universe, which sparked his lifelong passion for life sciences and finding solutions to complex problems. After completing high school, he decided to carry on the family tradition of engineering that had spanned three generations and pursued a career in bioengineering. With his expertise in Microbiology, Bioinformatics, Cell Culture, Murine Assays, Genetic Engineering, Synthetic Biology, and Origami, Axel became a skilled R&D scientist. At the young age of 22, he and his brother Alexis co-founded Polybion, a New Generation Materials Company, which soon earned Axel a spot as one of MIT Technology Review's Innovators Under 35. Today, he serves as both CEO and CTO of his company, and his groundbreaking work has led to the development of the world's first Bacterial Cellulose Biomanufacturing Facility. Axel's tireless efforts have paved the way for the rapid advancement of bioassembled products, increased sustainability, and a more efficient transition toward a circular economy. He is convinced that the intersection of biology and technology is the key to solving the global health crisis. He envisions a future in which humans and nature can coexist in harmony.

Have we created an operating system for life? How close are we to cloning humans, and what would that even look like? You're in for a fascinating episode as the line between science and science fiction gets blurred.  My guest is microbiologist and geneticist Andrew Hessel, the CEO and Founder of The Genome Project-Write, and author of "The Genesis Machine: Our Quest to Rewrite Life in the Age of Synthetic Biology." In this episode we discuss:➡️ How protein engineering has gone fully digital.➡️ How DNA is a coding language that we can access.➡️ Craig Ventner's work in transfecting a cell with a synthetic chromosome.➡️ The reality of human cloning.➡️ Stem cell banking and the future of medicine.➡️ What immortality could really look like.➡️ And more!To follow Andrew and learn more about his work, follow him on:Linked In - https://www.linkedin.com/in/andrewhessel/X - https://x.com/andrewhesselInstagram - https://www.instagram.com/syntheticgenomeguy/Check out his book, The Genesis Machine here - https://a.co/d/hcd2yOTFollow Dr. Bob Hariri on his platforms here:Web: www.pilotinghealth.comInstagram: https://www.instagram.com/drbobhariri/X: https://twitter.com/DrBobHaririTikTok: https://www.tiktok.com/@pilotinghealthLinkedIn: https://www.linkedin.com/in/drbobhariri/

Co-authors of Assembling Tomorrow: A Guide to Designing a Thriving Future, the authors, Scott Doorley, creative director, and Carissa Carter, academic director at Stanford University's d.school.Welcome you to Change Ready, an original series brought to you by Behind the Human & Malosi. A series where we do everything possible to future-proof your mind and thrive in an era of unprecedented change. ___How Prepared is Your Team for the Next Big Disruption? Future-proof your team with Malosiminds.com Get your copy of Personal Socrates: Better Questions, Better Life Connect with Marc >>> Website | LinkedIn | Instagram | Twitter Drop a review and let me know what resonates with you about the show!Thanks as always for listening and have the best day yet!*A special thanks to MONOS, our official travel partner for Behind the Human! Use MONOSBTH10 at check-out for savings on your next purchase. ✈️*Special props

Intelligence Notes: WEAPONIZED SYNTHETIC BIOLOGY Could Enable BIOWEAPONS DEVELOPMENT: Monkeypox,HIV, SARS, Ebola? part 2. To support the [Show] and its [Research] with Donations and Gifts, please send all funds and gifts to :$aigner2019 (cashapp) or https://www.paypal.me/Aigner2019 or Zelle (1-617-821-3168).

Synthetic biology, as showcased by Stephen Freeland's work at UMBC, redefines biological systems for groundbreaking applications in biotechnology and medicine, promising to solve global challenges and unlock new frontiers in science.Or, at least, that's what ChatGPT has to say about it. Our interview also covers how Artificial Intelligence is changing the wet-lab experience of doing research. Plus, the importance of the public domain in owning, understanding, and advancing all the many ways the future is taking shape.Read his original research : https://doi.org/10.3390/life13122281

• ​Intelligence Notes: WEAPONIZED SYNTHETIC BIOLOGY Could Enable BIOWEAPONS DEVELOPMENT. In this episode we will navigate through the Report acquired by the US Department of Defense (DOD). It is to be understood that there are many Institutions actively working on GoF(Gain of Function) Research. This research has in the past and will again in the future foster possible Bioweapon leaks etc. The use of Ai, Synthetic Biology, CRISPR tech etc. will increase the myriad possibilities of newly created Bioweapons which will in turn become an existential threat to humanity. To support the [Show] and its [Research] with Donations and Gifts, please send all funds and gifts to :$aigner2019 (cashapp) or https://www.paypal.me/Aigner2019 or Zelle me:(1-617-821-3168).

Forget Fan Mail, Fan Text Us!

Send us a Text Message.Unlock the secrets of cell factories and discover how cutting-edge technologies are revolutionizing biopharmaceutical production. In this episode, we welcome Mauro Torres, a postdoctoral researcher at the University of Manchester, who takes us on a fascinating journey through the complex world of protein manufacturing.Mauro Torres explains the intricate steps involved in the secretory pathway, from gene expression to protein export, likening it to a sophisticated car manufacturing process. He then delves into how omics technologies and systems-level approaches are enhancing our understanding of cell physiology and improving production effectiveness.Listeners will gain valuable insights into:The potential of AI and machine learning to navigate vast amounts of bioprocess dataHow synthetic biology is creating cells with new functionalities and improved adaptabilityThe exciting future of biopharmaceutical production as technologies convergeDiscover how these advancements are paving the way for more predictable, affordable, and robust medicine production, promising a brighter future for patients worldwide.Connect with Mauro Torres:Linkedin: https://www.linkedin.com/in/mauro-torres-sebNext Steps:Book a free assessment to help you develop biologics with peace of mind: https://bruehlmann-consulting.com

You might be familiar with plant-based alternatives to animal products — things like the Impossible Burger or Beyond Meat. And maybe you've heard of places trying to grow fish or meat cells in a dish to make sushi or steak without a fish or cow. But in today's episode we'll cover an old technology that's bringing us some new foods: precision fermentation. With precision fermentation, many everyday products including dairy-free milk, insulin, and the collagen in lotions are now being made by microbes. How did we turn microbes into teeny tiny production factories for so many different products, and where's the limit when it comes to what we can use them to create?In this episode we'll demystify the science behind this technology and its history. We'll also dive into how public perception influences the success of new food technologies and how framing can change minds and reduce both misinformation and skepticism.Send us your science stories/factoids/news here for a chance to be featured on an upcoming Tiny Show and Tell Us episode and to be entered to win a Tiny Matters coffee mug!Subscribe to our newsletter at bit.ly/tinymattersnewsletterLinks to the Tiny Show & Tell stories are here and here. Pick up a Tiny Matters mug here! All Tiny Matters transcripts are available here.

Send us a Text Message.Unlock the secrets of cell factories with Mauro Torres, a postdoctoral researcher at the University of Manchester who brings cutting-edge insights into protein production. Discover how the concept of cell factories has evolved from basic insulin extraction to groundbreaking treatments for genetic disorders and cancer. We reveal the challenges faced by biotech scientists in bioprocess development and offers a fascinating analogy between car manufacturing and cellular protein assembly.Learn how recent advancements in synthetic biology, genetic editing, and AI-driven process optimization are transforming the biopharmaceutical industry. From transposon technology to microfluidics and hybrid modeling, We explore the game-changing innovations that are accelerating cell line development and enhancing protein secretion.Gain valuable insights into:The evolution of cell factoriesCutting-edge technologies revolutionizing bioprocessingStrategies for reprogramming cells for enhanced protein productionDon't miss this episode packed with expert knowledge on the future of biomanufacturing.Connect with Mauro Torres:Linkedin: https://www.linkedin.com/in/mauro-torres-sebNext Steps:Book a free assessment to help you develop biologics with peace of mind: https://bruehlmann-consulting.com

Karthik, Mike, and Alina are joined by the founder of Fermbox Bio, Subramani Ramachandrappa, to discuss everything synthetic biology: the new business models that are unlocking scale-up, what products need to be successful, how consumers are responding, and even the future of food.

In this episode of the Life Science Success Podcast episode featuring Markus Gershater, co-founder of Synthace, listeners can learn about the intersection of synthetic biology, AI, and automation in revolutionizing life sciences research and development. Here are the key points: Role of Synthetic Biology and AI in Life Sciences: Markus discusses how Synthace leverages synthetic biology and AI to automate and enhance laboratory experiments, focusing on improving the efficiency and effectiveness of research processes. Design of Experiments (DOE): The conversation highlights the application of DOE, a statistical method that allows simultaneous examination of multiple input factors to determine their effect on a desired output, which is critical in managing the complexity of biological systems. Impact of Automation in Research: Markus explains how automation integrated through Synthace can significantly speed up and increase the precision of biological experiments, reducing the time and cost associated with traditional methods. Challenges and Opportunities with New Technologies: The discussion also covers the challenges of adopting new technologies in traditional research settings, the potential of AI to transform discovery processes, and the importance of aligning innovations with actual lab workflows. Vision and Aspirations for the Future: Markus shares his optimistic view on the potential of advanced technologies to make substantial impacts on life sciences, expressing hope and excitement about future possibilities to understand and control biological complexity more effectively. This episode provides insights into how cutting-edge technologies are shaping the future of biotechnological research and emphasizes the importance of integrating new tools with current scientific practices to maximize their benefits.

In this cutting edge episode of the Gut Health Gurus Podcast, host Kriben Govender, a renowned Food Scientist and nutritionist, interviews with Dr Amine a seasoned microbiome expert. Dr Amine Zorgani brings to light some interesting and novel microbiome research topics: Live Biotherapeutic Products, Reproductive and Infant health, Bacterial Vaginosis, vaginal health and much more. Topics Discussed: 00:00 - Dr Amine Zorgani's Story 04:20 - Dr Amine's passion from the microbiome 09:00 - From Engineering to Microbiome Research (Advice for Students) 13:41 - Approved Microbiome Based Therapies  21:18 - How are Live Biotherapeutic Products administered 23:52 - Novel Microbiome Technologies for Woman and Infants 30:00 - Synthetic Biology in Microbiome research  This episode is a must-watch for anyone interested in understanding the complex world of gut health, the science behind it, and practical approaches to improving gut-related health issues. About Dr Amine Zorgani:  Dr Amine, is a microbiome expert on a mission to save the human microbiome from extinction. Leveraging over a decade of research experience, he is at the forefront of efforts to unlock the potential of the microbiome. An engaging speaker at high-profile industry conferences, he shares his passion for realising the microbiome's potential to transform medicine. Amine's microbiome posts grab the attention of over 2.6 millions in the past year alone. He leads his team with an infectious optimism that, together, they can push scientific boundaries. His mantra is that perseverance and collaboration lead to breakthroughs. About Kriben Govender: Kriben Govender is a Food Scientist, Registered Nutritionist, and the founder of Nourishme Organics, a company specialising in gut health products. With over 20 years of experience in the food industry, Kriben is passionate about the intersection of diet, gut health, and well-being.   Sponsor: Nourishme Organics https://www.nourishmeorganics.com.au/collections/root-cause-protocol 10% off using code : happygut Microbiome Stool Testing, Deuterium Testing and Nutritional Consulting https://www.nourishmeorganics.com.au/collections/nutritionist-consultation   Connect with Kriben Govender here:  https://linktr.ee/kribengovender   Connect with Amine Zorgani https://microbiomemavericks.com/   Download links               If you enjoyed this episode and would like to show your support:   1) Please subscribe on Apple Podcasts, give us 5 stars and leave a positive review     Instructions:   - Click this link  https://itunes.apple.com/au/podcast/gut-health-gurus-podcast/id1433882512?mt=2   - Click "View in Itunes" button on the left-hand side - This will open the Itunes app - Click the "Subscribe" button - Click on "Ratings and Reviews" tab - Click on "Write a Review" button   Non-Itunes users can leave a Google Review here: https://goo.gl/9aNP0V     2) Subscribe, like and leave a positive comment on Youtube   https://www.youtube.com/channel/UCq5KxLvGIY4r6SqNaAphEUw?sub_confirmation=1   3) Share your favourite episode on Facebook, Instagram, and Stories 4) Let your friends and family know about this Podcast by email, text, messenger etc   Thank you so much for your support. It means the world to us.  

View show notes, transcript, and more on our Substack: https://designbetterpodcast.com/p/natsai-audrey-chieza Steve Jobs perfectly described the creative process when he said, “Creativity is just connecting the dots”. Innovation and new ideas are often found by combining the familiar in new ways. Natsai Audrey Chieza, founder of Faber Futures, is doing just that.  Natsai started her education as an architect, became fascinated by materials and transferred into biology, and today is designing new textiles, design processes, and manufacturing methods by harnessing biological technology. She's a rare individual who can hop between disciplines to design in new ways. We talk with Natsai about the work she and her team at Faber Futures are doing to help governments and large organizations design more sustainable products using bacteria, fungi, and algae as building tools, and how biophilic design technology could help us address climate change. Bio Natsai Audrey Chieza is a visionary designer and thought leader. She is the founder and CEO of Faber Futures and a co-founder of Normal Phenomena of Life (NPOL). Launched in 2018, Faber Futures is a pioneering design agency that melds consumer biotechnology advancements with real-world applications. In 2023, Chieza co-founded NPOL, a consumer brand offering biotech products online. NPOL makes tangible how biotechnology can generate new materials that can be beautifully designed to support climate goals and the cultivation of resilient bioeconomy value chains. ​Chieza's approach involves broad-ranging partnerships across biotech, consumer sectors, and cultural institutions. It uses collaborative, story-driven strategies to catalyse engagement and concrete action on critical issues. Notable clients and commissioning bodies include Ginkgo Bioworks, adidas, the Design Museum, MIT Media Lab, and the World Economic Forum (WEF).  ​As a member of the WEF's Global Futures Council on Synthetic Biology, Chieza advocates the integration of design and culture in policy development for bioeconomies powered by biotechnology. Her insights and leadership are sought after on various stages, including as a speaker at SxSW, TED, and Design Indaba. Chieza's contributions to biophilic design have earned her significant media coverage and accolades, including the 2019 INDEX award, known as the Nobel Prize for design. Premium Episodes on Design Better This ad-supported episode is available to everyone. If you'd like to hear it ad-free, upgrade to our premium subscription, where you'll get an additional 2 ad-free episodes per month (4 total). Premium subscribers also get access to our monthly AMAs with former guests, ad-free episodes, and our new enhanced newsletter The Brief that compiles salient insights, quotes, readings, and creative processes uncovered in the show.  Upgraid to paid Visiting the links below is one of the best ways to support our show: Methodical Coffee: Roasted, blended, brewed, served and perfected by verified coffee nerds

Modern biology is advancing by leaps and bounds, not only in understanding how organisms work, but in learning how to modify them in interesting ways. One exciting frontier is the study of tiny "robots" created from living molecules and cells, rather than metal and plastic. Gizem Gumuskaya, who works with previous guest Michael Levin, has created anthrobots, a new kind of structure made from living human cells. We talk about how that works, what they can do, and what future developments might bring.Blog post with transcript: https://www.preposterousuniverse.com/podcast/2024/04/29/274-gizem-gumuskaya-on-building-robots-from-human-cells/Support Mindscape on Patreon.Gimez Gumuskaya received her Ph.D. from Tufts University and the Harvard Wyss Institute for Biologically-Inspired Engineering. She is currently a postdoctoral researcher at Tufts University. She previously received a dual master's degree in Architecture and Synthetic Biology from MIT.Web siteGoogle scholar publicationsAnthrobots web siteSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How close are the technocrats to gaining control over all genetic material on planet Earth? After setting the stage with a recent article on the subject we will welcome back special guest, Elana Freeland ( ElanaFreeland.com ). Tonight we are going to tie together transhumanism from social, technological, and supernatural points of view, and in the second half we incorporate questions from the audience, and end with some comforting pro-human thoughts. Watch the full episode rerun here: https://share-link.pilled.net/topic-detail/882792 Proudly Sponsored By: Blue Monster Prep: An Online Superstore for Emergency Preparedness Gear (Storable Food, Water, Filters, Radios, MEDICAL SUPPLIES, and so much more). Use code 'FRANKLY' for Free Shipping on every purchase you make @ https://bluemonsterprep.com/ SUPPORT Quite Frankly: Official Merch: https://tinyurl.com/f3kbkr4s Official Coffee: https://tinyurl.com/2p9m8ndb Sponsor through QFTV: https://www.quitefrankly.tv/sponsor SubscribeStar: https://www.subscribestar.com/quitefrankly One-Time Tip: http://www.paypal.me/QuiteFranklyLive Sign up for the Free Mailing List: https://bit.ly/3frUdOj Send Crypto: BTC: 1EafWUDPHY6y6HQNBjZ4kLWzQJFnE5k9PK LTC: LRs6my7scMxpTD5j7i8WkgBgxpbjXABYXX ETH: 0x80cd26f708815003F11Bd99310a47069320641fC FULL Episodes On Demand: Spotify: https://spoti.fi/301gcES iTunes: http://apple.co/2dMURMq Amazon: https://amzn.to/3afgEXZ SoundCloud: http://bit.ly/2dTMD13 Google Play: https://bit.ly/2SMi1SF BitChute: https://bit.ly/2vNSMFq Rumble: https://bit.ly/31h2HUg Streaming Live On: QuiteFrankly.tv (Powered by Foxhole) DLive: https://bit.ly/2In9ipw Rokfin: https://bit.ly/3rjrh4q Twitch: https://bit.ly/2TGAeB6 YouTube: https://bit.ly/2exPzj4 Rumble: https://bit.ly/31h2HUg How Else to Find Us: Official WebSite: http://www.QuiteFrankly.tv Official Forum: https://bit.ly/3SToJFJ Official Telegram: https://t.me/quitefranklytv GUILDED Hangout: https://bit.ly/3SmpV4G Twitter: @QuiteFranklyTV Gab: @QuiteFrankly Truth Social: @QuiteFrankly GETTR: @QuiteFrankly MINDS: @QuiteFrankly